Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 317

Similar articles for PubMed (Select 17233861)

1.

Feasibility of screening for ovarian cancer using symptoms as selection criteria.

Rufford BD, Jacobs IJ, Menon U.

BJOG. 2007 Jan;114(1):59-64.

PMID:
17233861
2.

Results from an ultrasound-based familial ovarian cancer screening clinic: a 10-year observational study.

Tailor A, Bourne TH, Campbell S, Okokon E, Dew T, Collins WP.

Ultrasound Obstet Gynecol. 2003 Apr;21(4):378-85.

3.

Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening.

Menon U, Talaat A, Rosenthal AN, Macdonald ND, Jeyerajah AR, Skates SJ, Sibley K, Oram DH, Jacobs IJ.

BJOG. 2000 Feb;107(2):165-9.

PMID:
10688498
4.

Screening postmenopausal women for ovarian cancer: a systematic review.

Fung MF, Bryson P, Johnston M, Chambers A; Cancer Care Ontario Practice Guidelines Initiative Gynecology Cancer Disease Site Group.

J Obstet Gynaecol Can. 2004 Aug;26(8):717-28. Review.

PMID:
15307976
5.

Pre- and postmenopausal high-risk women undergoing screening for ovarian cancer: anxiety, risk perceptions, and quality of life.

Hensley ML, Robson ME, Kauff ND, Korytowsky B, Castiel M, Ostroff J, Hurley K, Hann LE, Colon J, Spriggs D.

Gynecol Oncol. 2003 Jun;89(3):440-6.

PMID:
12798709
6.

Prevalence of ovarian cancer among women with a CA125 level of 35 U/ml or less.

Kobayashi H, Yamada Y, Sado T, Sakata M, Yoshida S, Kawaguchi R, Kanayama S, Shigetomi H, Haruta S, Tsuji Y, Ueda S, Kitanaka T, Oi H.

Gynecol Obstet Invest. 2008;65(2):133-8. Epub 2007 Oct 23.

PMID:
17957102
7.

Compliance of average- and intermediate-risk women to semiannual ovarian cancer screening.

Drescher CW, Nelson J, Peacock S, Andersen MR, McIntosh MW, Urban N.

Cancer Epidemiol Biomarkers Prev. 2004 Apr;13(4):600-6.

8.

A randomized study of screening for ovarian cancer: a multicenter study in Japan.

Kobayashi H, Yamada Y, Sado T, Sakata M, Yoshida S, Kawaguchi R, Kanayama S, Shigetomi H, Haruta S, Tsuji Y, Ueda S, Kitanaka T.

Int J Gynecol Cancer. 2008 May-Jun;18(3):414-20. Epub 2007 Jul 21.

PMID:
17645503
9.

Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer.

Menon U, Skates SJ, Lewis S, Rosenthal AN, Rufford B, Sibley K, Macdonald N, Dawnay A, Jeyarajah A, Bast RC Jr, Oram D, Jacobs IJ.

J Clin Oncol. 2005 Nov 1;23(31):7919-26.

10.

[Program for early detection of ovarian cancer for women as prophylaxis provided at a municipal hospital].

Cnota W, Sodowski K, Olesiak-Andryszczak M, Pilch-Kowalczyk M.

Wiad Lek. 2004;57 Suppl 1:43-7. Polish.

PMID:
15884203
11.

Feasibility study of a randomised trial of ovarian cancer screening among the general population.

Parkes CA, Smith D, Wald NJ, Bourne TH.

J Med Screen. 1994 Oct;1(4):209-14.

PMID:
8790521
12.

Follow up of women with simple ovarian cysts detected by transvaginal sonography in the Tokyo metropolitan area.

Sasaki H, Oda M, Ohmura M, Akiyama M, Liu C, Tsugane S, Terashima Y, Tanaka T.

Br J Obstet Gynaecol. 1999 May;106(5):415-20.

PMID:
10430190
13.

Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging.

Bourne TH, Campbell S, Reynolds KM, Whitehead MI, Hampson J, Royston P, Crayford TJ, Collins WP.

BMJ. 1993 Apr 17;306(6884):1025-9.

14.

Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation.

Menon U, Talaat A, Jeyarajah AR, Rosenthal AN, MacDonald ND, Skates SJ, Sibley K, Oram DH, Jacobs IJ.

Br J Cancer. 1999 Jul;80(10):1644-7.

15.

Feasibility study of a randomised trial of ovarian cancer screening.

Tabor A, Jensen FR, Bock JE, H√łgdall CK.

J Med Screen. 1994 Oct;1(4):215-9.

PMID:
8790522
16.

The performance of screening tests for ovarian cancer: results of a systematic review.

Bell R, Petticrew M, Sheldon T.

Br J Obstet Gynaecol. 1998 Nov;105(11):1136-47. Review.

PMID:
9853761
17.

Screening for ovarian cancer by transvaginal ultrasound and serum CA125 measurement in women with a familial predisposition: a prospective cohort study.

Bosse K, Rhiem K, Wappenschmidt B, Hellmich M, Madeja M, Ortmann M, Mallmann P, Schmutzler R.

Gynecol Oncol. 2006 Dec;103(3):1077-82. Epub 2006 Aug 9.

PMID:
16904167
18.

Screening for ovarian cancer in the general population.

Chu CS, Rubin SC.

Best Pract Res Clin Obstet Gynaecol. 2006 Apr;20(2):307-20. Epub 2005 Dec 20. Review.

PMID:
16364690
19.

Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project.

Gilbert L, Basso O, Sampalis J, Karp I, Martins C, Feng J, Piedimonte S, Quintal L, Ramanakumar AV, Takefman J, Grigorie MS, Artho G, Krishnamurthy S; DOvE Study Group.

Lancet Oncol. 2012 Mar;13(3):285-91. doi: 10.1016/S1470-2045(11)70333-3. Epub 2012 Jan 17.

PMID:
22257524
20.

Annual surveillance by CA125 and transvaginal ultrasound for ovarian cancer in both high-risk and population risk women is ineffective.

Woodward ER, Sleightholme HV, Considine AM, Williamson S, McHugo JM, Cruger DG.

BJOG. 2007 Dec;114(12):1500-9. Epub 2007 Sep 27.

PMID:
17903229
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk